Moderna
MRNA
#1287
Rank
โ‚น1.707 T
Marketcap
โ‚น4,305
Share price
-1.24%
Change (1 day)
84.45%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -โ‚น239.96 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น1.92 Billion. , an increase over its 2024 earnings that were of -โ‚น339.96 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น261.68 Billion-23.03%
2024 -โ‚น339.96 Billion-8.22%
2023 -โ‚น370.42 Billion-140.65%
2022 โ‚น911.22 B-27.81%
2021 โ‚น1.262 T-1911.15%
2020 -โ‚น69.69 Billion44.7%
2019 -โ‚น48.17 Billion28.63%
2018 -โ‚น37.45 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.183 T-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.551 T-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น2.127 T-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.51 Billion-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.17 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.97 Billion-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น54.62 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น32.74 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA